Managing localized prostate cancer in the era of prostate-specific antigen screening


  • James D. Brooks MD

    Corresponding author
    1. Department of Urology, Stanford University, Stanford, California
    • Corresponding author: James D. Brooks, MD, Department of Urology, Room S287, Stanford University School of Medicine, 300 Pasteur Drive, Stanford, CA 94305-5118; Fax: (650) 723-4200;

    Search for more papers by this author


A predictive tool has been developed and validated that identifies patients with low-risk cancer on biopsy who are at risk for upgrading at surgery. This tool could help increase acceptance and safety of active surveillance and lower the number of men overtreated for low-risk prostate cancer.